Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Ja-Hong Kim, MD

Advertisement

Articles by Ja-Hong Kim, MD

Majority of nocturia patients have nocturnal polyuria

ByJa-Hong Kim, MD,Shlomo Raz, MD
November 1st 2009

Drs. Shlomo Raz and Ja-Hong Kim discuss recent advances in the treatment of stress incontinence.

Advertisement

Latest Updated Articles

  • Majority of nocturia patients have nocturnal polyuria
    Majority of nocturia patients have nocturnal polyuria

    November 1st 2009



Advertisement
Advertisement

Trending on Urology Times

1

The Evolving Landscape of Minimally Invasive BPH Therapy

2

TURP, HoLEP, and the Future of Minimally Invasive BPH Therapy

3

FDA grants priority review to perioperative durvalumab plus enfortumab vedotin in MIBC

4

AACU, WOCN Society urge safeguards in Medicare catheter bidding

5

FDA approves belzutifan plus lenvatinib for advanced clear cell renal cell carcinoma

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us